Swine Healthcare Market Size, Share, Industry Analysis 2023-2028

The latest research study “Swine Healthcare Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that The global swine healthcare market size reached US$ 2.78 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.33 Billion by 2028, exhibiting a growth rate (CAGR) of 7.42% during 2023-2028.

Swine healthcare refers to a broad category of treatment procedures, products, and diagnostic kits that aim to relieve discomfort during swine diseases. It focuses on remedies for common pig-related disorders, such as infertility and congenital anomalies, and the development of therapeutics to prevent such infections. Swine healthcare management includes coordinated global disease monitoring, targeted research investments that minimize future threat effects, and data analysis. In addition, the treatment also involves the prevention of viruses and bacteria while enhancing herd disease immunity with properly timed vaccinations and responsible antibiotic use. The swine healthcare system promotes minimizing disease risks through pig movement, vaccination protocols, herd health monitoring, barn design, disease surveillance, and diagnostic tests that are appropriate for the situation.

Swine Healthcare Market Trends and Drivers:

The escalating commercial pig farming and export activities across the globe and the rising prevalence of various diseases, including swine flu, salmonella, mycoplasma hyopneumoniae, and classical swine fever (CSF) are among the primary factors driving the swine healthcare market. Besides this, the increasing awareness toward pork-transmitted diseases and the launch of several policies by the government bodies to promote pig healthiness are further augmenting the market growth. Moreover, the extensive research and development (R&D) activities with an enhanced focus on the introduction of vaccines to prevent swine flu and swine fever and reduce the effects of pig diseases on humans are also catalyzing the global market. Apart from this, the incorporation of diagnostic imaging techniques in veterinary hospitals, leading to an elevating demand for accessories and equipment, is acting as another significant growth-inducing factor. Furthermore, the growing popularity of vaccines, antibiotics, and surgical treatments for increasing livestock production, the high rates of foodborne diseases, the emerging trend of globalization, and the inflating need for organic pork are expected to bolster the swine healthcare market in the coming years.

Swine Healthcare Market 2023-2028 Analysis and Segmentation:

The report has segmented the market on the basis of

Product Insights

• Diagnostic Tests
  • Enzyme Linked Immuno-Sorbent Assay (ELISA)
  • Rapid Immuno Migration (RIM)
  • Agar Gel Immuno-Diffusion (AGID)
  • Polymerase Chain Reaction (PCR)
  • Diagnostic Imaging
  • Others
• Therapeutics
  • Vaccines
  • Parasiticides
  • Anti-infectives
  • Feed Additives
  • Others

The report has also provided a detailed breakup and analysis of the swine healthcare market based on the product. This includes diagnostic tests (Enzyme Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging, and others) and therapeutics (vaccines, parasiticides, anti-infectives, feed additives, and others). According to the report, therapeutics represented the largest segment.

 

Disease Insights

• Exudative Dermatitis
• Coccidiosis
• Respiratory Diseases
• Swine Dysentery
• Porcine Parvovirus
• Others

A detailed breakup and analysis of the swine healthcare market based on the disease has also been provided in the report. This includes exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, porcine parvovirus, and others. According to the report, respiratory diseases accounted for the largest market share.

Route of Administration Insights

• Injectable
• Oral

A detailed breakup and analysis of the swine healthcare market based on the route of administration has also been provided in the report. This includes injectable and oral.

Distribution Channel Insights

• Veterinary Hospitals
• Retail Pharmacy
• Online Pharmacy

A detailed breakup and analysis of the swine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals, retail pharmacy and online pharmacy.

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Boehringer Ingelheim International GmbH, Ceva Animal Health Inc., Elanco, IDEXX Laboratories Inc., Innovative Diagnostic, Merck & Co. Inc., Phibro Animal Health Corporation, Vetoquinol, Virbac Corporation, Zoetis Inc., etc.

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Contact Us:

IMARC Services Private Limited.

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.